PSP001 - A First-in-disease human PEGIFN-λ Chimera

Jan 7th, 2021 FDA IND Submission;
Date:2019-08-05 18:47:50 | Visits:


 
 Prev:Feb 3rd 2021. FDA issued letter "Safe-to-proceed";
 Next:Status:Q4 2019, FDA Pre-IND Meeting;